✦ LIBER ✦

Treatment of advanced pancreatic carcinoma with the somatostatin analogue BIM 23014. Preliminary results of a pilot study

✍ Scribed by Luciano Canobbio; Francesco Boccardo; Daniela Cannata; Pietro Gallotti; Renzo Epis

Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 284 KB
Volume: 69
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19920201)69:3<648::aid-cncr2820690308>3.0.co;2-j

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase III evaluation of a somatostatin

A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma

✍ David L. Morris 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 1 views

I of a Somatostatin Analogue (Octreotide) in the Treatment of Patients with Asymptomatic Advanced Colon Cancer."' The disappointing results of this study contrast with recently reported cellular kinetic data for rectal cancer treatment with somatostatin. It should be noted that the dosage used in o

A phase III evaluation of a somatostatin

A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma

✍ Richard M. Goldberg; Charles G. Moertel; Harry S. Wieand; James E. Krook; Allan 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB

Phase II study of gemcitabine and cispla

Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma

✍ Philip A. Philip; Mark M. Zalupski; V. K. Vaitkevicius; Patricia Arlauskas; Ruth 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views